Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy SL Van Driest, VC Vasile, SR Ommen, ML Will, AJ Tajik, BJ Gersh, ... Journal of the American College of Cardiology 44 (9), 1903-1910, 2004 | 509 | 2004 |
Return of genomic results to research participants: the floor, the ceiling, and the choices in between GP Jarvik, LM Amendola, JS Berg, K Brothers, EW Clayton, W Chung, ... The American Journal of Human Genetics 94 (6), 818-826, 2014 | 424 | 2014 |
Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing SL Van Driest, Y Shi, EA Bowton, JS Schildcrout, JF Peterson, J Pulley, ... Clinical Pharmacology & Therapeutics 95 (4), 423-431, 2014 | 337 | 2014 |
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy KR Crews, AA Monte, R Huddart, KE Caudle, ED Kharasch, A Gaedigk, ... Clinical Pharmacology & Therapeutics 110 (4), 888-896, 2021 | 277 | 2021 |
Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy SL Van Driest, EG Ellsworth, SR Ommen, AJ Tajik, BJ Gersh, ... Circulation 108 (4), 445-451, 2003 | 270 | 2003 |
Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations J Binder, SR Ommen, BJ Gersh, SL Van Driest, AJ Tajik, RA Nishimura, ... Mayo Clinic Proceedings 81 (4), 459-467, 2006 | 265 | 2006 |
Prevalence and severity of “benign” mutations in the β-myosin heavy chain, cardiac troponin T, and α-tropomyosin genes in hypertrophic cardiomyopathy SL Van Driest, MJ Ackerman, SR Ommen, R Shakur, ML Will, ... Circulation 106 (24), 3085-3090, 2002 | 251 | 2002 |
Yield of genetic testing in hypertrophic cardiomyopathy SL Van Driest, SR Ommen, AJ Tajik, BJ Gersh, MJ Ackerman Mayo Clinic Proceedings 80 (6), 739-744, 2005 | 240 | 2005 |
Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy SL Van Driest, MA Jaeger, SR Ommen, ML Will, BJ Gersh, AJ Tajik, ... Journal of the American College of Cardiology 44 (3), 602-610, 2004 | 233 | 2004 |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing JJ Lima, CD Thomas, J Barbarino, Z Desta, SL Van Driest, N El Rouby, ... Clinical Pharmacology & Therapeutics 109 (6), 1417-1423, 2021 | 217 | 2021 |
Sarcomeric genotyping in hypertrophic cardiomyopathy SL Van Driest, SR Ommen, AJ Tajik, BJ Gersh, MJ Ackerman Mayo Clinic Proceedings 80 (4), 463-469, 2005 | 194 | 2005 |
Phenotype risk scores identify patients with unrecognized Mendelian disease patterns L Bastarache, JJ Hughey, S Hebbring, J Marlo, W Zhao, WT Ho, ... Science 359 (6381), 1233-1239, 2018 | 193 | 2018 |
Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records SL Van Driest, QS Wells, S Stallings, WS Bush, A Gordon, DA Nickerson, ... Jama 315 (1), 47-57, 2016 | 189 | 2016 |
Biobanks and electronic medical records: enabling cost-effective research E Bowton, JR Field, S Wang, JS Schildcrout, SL Van Driest, JT Delaney, ... Science translational medicine 6 (234), 234cm3-234cm3, 2014 | 136 | 2014 |
Acute kidney injury incidence in noncritically ill hospitalized children, adolescents, and young adults: a retrospective observational study TL McGregor, DP Jones, L Wang, I Danciu, BC Bridges, GM Fleming, ... American Journal of Kidney Diseases 67 (3), 384-390, 2016 | 131 | 2016 |
Gene-specific modifying effects of pro-LVH polymorphisms involving the renin–angiotensin–aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy MJ Perkins, SL Van Driest, EG Ellsworth, ML Will, BJ Gersh, SR Ommen, ... European heart journal 26 (22), 2457-2462, 2005 | 130 | 2005 |
Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia SE Karol, W Yang, SL Van Driest, TY Chang, S Kaste, E Bowton, ... Blood, The Journal of the American Society of Hematology 126 (15), 1770-1776, 2015 | 112 | 2015 |
Harmonizing clinical sequencing and interpretation for the eMERGE III network H Zouk, E Venner, NJ Lennon, DM Muzny, D Abrams, S Adunyah, ... The American Journal of Human Genetics 105 (3), 588-605, 2019 | 93 | 2019 |
Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome P Weeke, JD Mosley, D Hanna, JT Delaney, C Shaffer, QS Wells, ... Journal of the American College of Cardiology 63 (14), 1430-1437, 2014 | 91 | 2014 |
Benefit of preemptive pharmacogenetic information on clinical outcome DM Roden, SL Van Driest, JD Mosley, QS Wells, JR Robinson, JC Denny, ... Clinical Pharmacology & Therapeutics 103 (5), 787-794, 2018 | 89 | 2018 |